PipelineReview.com19 小时
ELAHERE® (mirvetuximab soravtansine-gynx) Shows Consistent Survival Benefit in Long-Term ...
NORTH CHICAGO, IL, USA I March 15, 2025 I AbbVie (NYSE: ABBV) today announced the final analysis of the confirmatory Phase 3 MIRASOL trial evaluating the ...
Scientists link 'poor diet' to higher risk of surprising cancer in new research
Lifestyle choices can severely impact our risk of cancer development, even ones that may not seem diet related ...